Alignment Healthcare reported strong second-quarter results, exceeding guidance on membership, revenue, adjusted gross profit, and adjusted EBITDA. The company's medical benefits ratio was the lowest since the IPO.
The second quarter marks the company's lowest medical benefits ratio since the IPO.
The company beat guidance on four key performance indicators: membership, revenue, adjusted gross profit and adjusted EBITDA.
The company expects to build upon this momentum and remain confident in their team’s ability to achieve their full-year financial targets.
Planned 2023 market expansions are subject to regulatory approval.
The company is confident in their team’s ability to achieve their full-year financial targets.